Valeant bids for Cold-FX maker Afexa
Tuesday, August 30, 2011 - 12:00
in Mathematics & Economics
Valeant Pharmaceuticals International Inc. has joined the fray to acquire Afexa Life Sciences Inc. with a $76-million bid for the Alberta-based maker of Cold-FX.
